Overview
To investigate the safety and efficacy of the moisturizing lotion in improving eczema symptoms among individuals with atopic eczema in Malaysia. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4.
The main questions this study aims to answer are:
- To investigate the safety of the moisturizing lotion for individuals with atopic eczema in Malaysia.
- To determine the efficacy of the moisturizing lotion in improving eczema lesions among individuals with atopic eczema in Malaysia.
- To assess the participants' satisfaction after using the moisturizing lotion.
Eligibility
Inclusion Criteria:
- Healthy Malaysian women and men
- Age above 18 years old
- Clinically diagnosed with eczema with mild to moderate severity on any parts of the body as evaluated by Eczema Area and Severity Index (EASI) (score 10-20).
Exclusion Criteria:
- History of allergies or adverse reactions to moisturizers or components of the specific products being tested
- History of chronic allergies
- Pregnant, breastfeeding women, or those planning pregnancy during the study period
- Participants with documented autoimmune diseases.
- Currently undergoing or requiring active drug treatment for atopic dermatitis or eczema
- Use of any medication (topical or systemic) that could interfere with the study aim (e.g. corticosteroids, calcineurin inhibitors, methotrexate) 3 months prior to the start of the study treatment and throughout the study
- Current participation in another interventional clinical study
- Presence of dermatological or systemic disorder other than eczema that could interfere with study outcomes
